Fei Han

11.4k citations

257 papers · 7.3k indexed · 2 hit papers · h-index 46

Impact in

Otorhinolaryngology top 0.05%
- Head and Neck Cancer Studies
Oncology top 1%
- Lung Cancer Research Studies

Papers in ⓘ

Otorhinolaryngology 110
- Head and Neck Cancer Studies 110
Surgery 80
- Head and Neck Surgical Oncology 48
- Cholangiocarcinoma and Gallbladder Cancer Studies 19

Co-authors: Chong Zhao (57 shared papers)Weiwei Xiao (38 shared papers)Xiaowu Deng (39 shared papers)Tai-Xiang Lu (25 shared papers)Tai‐Xiang Lu (22 shared papers)Liming Chen (11 shared papers)Bei Sun (11 shared papers)Peng Hu (27 shared papers)
Journals: Magnetic Resonance in Medicine (21 papers)International Journal of Radiation Oncology*Biology*Physics (14 papers)Journal of Cardiovascular Magnetic Resonance (7 papers)Head & Neck (7 papers)Radiation Oncology (7 papers)
Partner nations: China United States Germany

In The Last Decade

Fei Han

250 papers receiving 7.3k citations

Hit Papers

align trajectories log scale

SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart 2019 · 442 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2019 Cardiovascular Diabetology
2013 Radiotherapy and Oncology

Peers

Countries citing papers authored by Fei Han

Since Specialization

Citations

This map shows the geographic impact of Fei Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Han more than expected).

Fields of papers citing papers by Fei Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Han. The network helps show where Fei Han may publish in the future.

Co-authors

The 25 scholars most cited alongside Fei Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fei Han Line = papers co-authored together Fei Han links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 257 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart Cardiovascular Diabetology ·Chenguang Li, Jie Zhang, Mei Xue, Xiaoyu Li, Fei Han, Xiangyang Liu, Linxin Xu, Yunhong Lu, Ying Cheng, Ting Li, Xiaochen Yu, Bei Sun, Liming Chen Hit paper breakdown →	2019	442
2	Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: An analysis of survival and treatment toxicities Radiotherapy and Oncology ·Xueming Sun, Shengfa Su, Chunyan Chen, Fei Han, Chong Zhao, Weiwei Xiao, Xiaowu Deng, Shaomin Huang, Chengguang Lin, Tai‐Xiang Lu Hit paper breakdown →	2013	433
3	CD155T/TIGIT Signaling Regulates CD8+ T-cell Metabolism and Promotes Tumor Progression in Human Gastric Cancer Cancer Research ·Weiling He, Hui Zhang, Fei Han, Xinlin Chen, Run Lin, Wei Wang, Haibo Qiu, Zhenhong Zhuang, Qi Liao, Weijing Zhang, Qinbo Cai, Yongmei Cui, Wenting Jiang, Han Wang, Zunfu Ke	2017	261
4	Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy Cancer ·Weiwei Xiao, Shaomin Huang, Fei Han, Shaoxiong Wu, Lixia Lu, Cheng‐Guang Lin, Xiaowu Deng, Tai‐Xiang Lu, Nian‐Ji Cui, Chong Zhao	2010	214
5	Long-Term Outcomes of Early-Stage Nasopharyngeal Carcinoma Patients Treated With Intensity-Modulated Radiotherapy Alone International Journal of Radiation OncologyBiologyPhysics ·Sheng-Fa Su, Fei Han, Chong Zhao, Chun-Yan Chen, Weiwei Xiao, Jia-Xin Li, Tai-Xiang Lu	2010	171
6	MicroRNA‐21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice FEBS Letters ·Zheng Zhang, Huimin Peng, Junxia Chen, Xin Chen, Fei Han, Xiaoming Xu, Xiao-yan He, Ning Yan	2009	154
7	Long-term Outcomes and Prognostic Factors of Re-irradiation for Locally Recurrent Nasopharyngeal Carcinoma using Intensity-modulated Radiotherapy Clinical Oncology ·Fei Han, Chong Zhao, Shao-Min Huang, Li-Xia Lu, Ying Huang, Xiaowu Deng, Wei-Yuan Mai, Bin S. Teh, E. Brian Butler, Tai-Xiang Lu	2011	122
8	Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy European Journal of Cancer ·Yi-Jun Hua, Fei Han, Li-Xia Lu, Hai-Qiang Mai, Xiang Guo, Ming‐Huang Hong, Tai-Xiang Lu, Chong Zhao	2012	120
9	Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma International Journal of Radiation OncologyBiologyPhysics ·Tai-Xiang Lu, Wei-Yuan Mai, Bin S. Teh, Chong Zhao, Fei Han, Yin Huang, Xiaowu Deng, Li-Xia Lu, Shao-Min Huang, Zhi-Fan Zeng, Cheng‐Guang Lin, Hsin H Lu, Joseph Chiu, L.Steven Carpenter, Walter H. Grant, Shiao Y. Woo, Nan-Ji Cui, E. Brian Butler	2004	116
10	Triptolide Restores Autophagy to Alleviate Diabetic Renal Fibrosis through the miR-141-3p/PTEN/Akt/mTOR Pathway Molecular Therapy — Nucleic Acids ·Xiaoyu Li, Shanshan Wang, Zhe Han, Fei Han, Yunpeng Chang, Yang Yang, Mei Xue, Bei Sun, Liming Chen	2017	116
11	Phase III Study Comparing Standard Radiotherapy With or Without Weekly Oxaliplatin in Treatment of Locoregionally Advanced Nasopharyngeal Carcinoma: Preliminary Results Journal of Clinical Oncology ·Li Zhang, Chong Zhao, Pei-Jian Peng, Li-Xia Lu, Pei‐Yu Huang, Fei Han, Shao-Xiong Wu	2005	113
12	Increased expression of the lncRNA PVT1 is associated with poor prognosis in pancreatic cancer patients. PubMed ·C Huang, Wenjie Yu, Qinghai WANG, Hongmei Cui, Y Wang, Lingling Zhang, Fei Han, Tse‐Hung Huang	2015	106
13	Triptolide Attenuates Renal Tubular Epithelial-mesenchymal Transition Via the MiR-188-5p-mediated PI3K/AKT Pathway in Diabetic Kidney Disease International Journal of Biological Sciences ·Mei Xue, Ying Cheng, Fei Han, Yunpeng Chang, Yang� Yang, Xiaoyu Li, Li Chen, Yunhong Lu, Bei Sun, Liming Chen	2018	93
14	Different Clinical Significance of Pre- and Post-treatment Plasma Epstein–Barr Virus DNA Load in Nasopharyngeal Carcinoma Treated with Radiotherapy Clinical Oncology ·Xue Hou, Chong Zhao, Ying Guo, Fei Han, Li-Xia Lu, Shao-Xiong Wu, Li Su, Pei‐Yu Huang, He Huang, Li Zhang	2010	93
15	Empagliflozin Attenuates Hyperuricemia by Upregulation of ABCG2 via AMPK/AKT/CREB Signaling Pathway in Type 2 Diabetic Mice International Journal of Biological Sciences ·Yunhong Lu, Yunpeng Chang, Ting Li, Fei Han, Chunjun Li, Xiaoyu Li, Mei Xue, Ying Cheng, Ziyu Meng, Zhe Han, Bei Sun, Liming Chen	2020	90
16	Treatment Outcomes After Radiotherapy Alone for Patients With Early-Stage Nasopharyngeal Carcinoma International Journal of Radiation OncologyBiologyPhysics ·Weiwei Xiao, Fei Han, Tai-Xiang Lu, Chun-Yan Chen, Ying Huang, Chong Zhao	2009	88
17	Salvage endoscopic nasopharyngectomy is superior to intensity-modulated radiation therapy for local recurrence of selected T1–T3 nasopharyngeal carcinoma – A case-matched comparison Radiotherapy and Oncology ·Rui You, Xiong Zou, Yi-Jun Hua, Fei Han, Li Li, Chong Zhao, Ming‐Huang Hong, Ming‐Yuan Chen	2015	80
18	Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma Annals of Oncology ·Xin Wu, Pei Huang, Pei Peng, Lixia Lu, Fei Han, Siming Wu, Xiaojuan Hou, Hong Yu Zhao, Yunjian Huang, W.F. Fang, Yuanyuan Zhao, Chunyan Xue, Zhanying Hu, J. Zhang, Jiajian Zhang, Yifeng Ma, Wenhua Liang, Chong Zhao, Liyuan Zhang	2013	80
19	Late toxicities after intensity-modulated radiotherapy for nasopharyngeal carcinoma: patient and treatment-related risk factors British Journal of Cancer ·Lei Zeng, Y-M Tian, X-M Sun, C-Y Chen, Fei Han, Weiwei Xiao, Xiaowu Deng, T-X Lu	2013	78
20	Dihydroartemisinin induces pyroptosis by promoting the AIM2/caspase-3/DFNA5 axis in breast cancer cells Chemico-Biological Interactions ·Yaqiong Li, Wei Wang, Aixia Li, Wei Huang, Shiman Chen, Fei Han, Lingcheng Wang	2021	78

About Fei Han

Fei Han is a scholar working on Otorhinolaryngology, Surgery, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology, having authored 257 papers that have together received 7.3k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (110 papers), Advanced MRI Techniques and Applications (48 papers), Head and Neck Surgical Oncology (48 papers), Lung Cancer Research Studies (23 papers), Lung Cancer Treatments and Mutations (21 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (19 papers), Brain Metastases and Treatment (17 papers) and Lung Cancer Diagnosis and Treatment (17 papers). The work is most often cited by research in Otorhinolaryngology (3.1k citations), Oncology (1.9k citations), Radiology, Nuclear Medicine and Imaging (1.5k citations), Cancer Research (919 citations) and Surgery (2.4k citations). Fei Han has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Chong Zhao, Weiwei Xiao, Xiaowu Deng, Tai-Xiang Lu, Tai‐Xiang Lu, Liming Chen, Bei Sun, Peng Hu, Ying Huang and Li-Xia Lu. Their work appears in journals such as Magnetic Resonance in Medicine, International Journal of Radiation Oncology*Biology*Physics, Journal of Cardiovascular Magnetic Resonance, Head & Neck and Radiation Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact